A detailed history of Cibc World Market Inc. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Cibc World Market Inc. holds 57,835 shares of ONCY stock, worth $54,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,835
Previous 58,150 0.54%
Holding current value
$54,364
Previous $62,000 8.06%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$0.99 - $1.24 $311 - $390
-315 Reduced 0.54%
57,835 $57,000
Q1 2024

May 13, 2024

SELL
$0.89 - $1.36 $2,435 - $3,722
-2,737 Reduced 4.5%
58,150 $62,000
Q4 2023

Feb 13, 2024

SELL
$1.22 - $2.09 $31 - $54
-26 Reduced 0.04%
60,887 $82,000
Q2 2023

Aug 11, 2023

SELL
$1.11 - $2.74 $186 - $460
-168 Reduced 0.28%
60,913 $161,000
Q1 2023

May 12, 2023

BUY
$1.2 - $1.91 $26 - $42
22 Added 0.04%
61,081 $75,000
Q4 2022

Feb 13, 2023

SELL
$1.17 - $2.12 $491 - $890
-420 Reduced 0.68%
61,059 $100,000
Q3 2022

Nov 10, 2022

BUY
$0.98 - $1.51 $11 - $18
12 Added 0.02%
61,479 $77,000
Q2 2022

Aug 10, 2022

SELL
$0.85 - $1.59 $6,363 - $11,902
-7,486 Reduced 10.86%
61,467 $60,000
Q1 2022

May 12, 2022

BUY
$1.31 - $2.02 $10,904 - $16,814
8,324 Added 13.73%
68,953 $109,000
Q4 2021

Feb 14, 2022

SELL
$1.39 - $2.3 $1,424 - $2,357
-1,025 Reduced 1.66%
60,629 $84,000
Q3 2021

Nov 12, 2021

SELL
$1.93 - $2.77 $551 - $792
-286 Reduced 0.46%
61,654 $129,000
Q2 2021

Aug 12, 2021

SELL
$2.6 - $4.64 $135 - $241
-52 Reduced 0.08%
61,940 $172,000
Q4 2020

Feb 08, 2021

BUY
$1.71 - $4.03 $2,229 - $5,255
1,304 Added 2.15%
61,992 $148,000
Q3 2020

Nov 12, 2020

SELL
$1.58 - $2.15 $624 - $849
-395 Reduced 0.65%
60,688 $103,000
Q2 2020

Aug 13, 2020

BUY
$1.33 - $2.76 $58,098 - $120,565
43,683 Added 251.05%
61,083 $115,000
Q1 2020

May 15, 2020

BUY
$0.98 - $4.28 $202 - $885
207 Added 1.2%
17,400 $24,000
Q4 2019

Feb 13, 2020

BUY
$0.42 - $4.76 $7,221 - $81,838
17,193 New
17,193 $82,000

Others Institutions Holding ONCY

About ONCOLYTICS BIOTECH INC


  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $54.4M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.